Table IV.

Adjusted inverse probability of treatment weighting outcomes in obese patients with and without metabolic syndrome.

Complication or other outcome	Obese with Mets, %	Obese without MetS, %	p-value
Length of stay, days	3.3	3.2	< 0.0001*
Discharge home	63.53	65.81	< 0.0001†
Central nervous system	0.07	0.09	0.1000†
Cardiac	0.65	0.64	0.6866†
Deep vein thrombosis	0.32	0.36	0.0748†
Gastrointestinal	0.24	0.25	0.3441†
Genitourinary	0.51	0.49	0.5156†
Haematoma/seroma	0.53	0.57	0.1117†
Postoperative Infection	0.15	0.17	0.1176†
Pulmonary embolism	0.46	0.49	0.1177†
Postoperative anaemia	24.16	21.86	< 0.0001†
Peripheral vascular disease	0.10	0.12	0.0586†
Respiratory	0.13	0.15	0.1959†
Wound dehiscence	0.11	0.11	0.9873†

^*Independent-samples t-test.

^†Chi-squared test.

MetS, metabolic syndrome.